26.767.12 101st Legislative Session 1162
ENROLLED
An Act
ENTITLED An Act to add certain substances to Schedule I of the controlled substances schedule.
Be it enacted by the Legislature of the State of South Dakota:
Section 1. That § 34-20B-12 be AMENDED:
34-20B-12. Any of the following substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, is included in Schedule I, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:
(1) Acetylmethadol;
(2) Allylprodine;
(3) Alphacetylmethadol, except levo-alphacetylmethadol, also known as levo-alpha-acetylmethadol, levomethadyl acetate or LAAM;
(4) Alphameprodine;
(5) Alphamethadol;
(6) Benzethidine;
(7) Betacetylmethadol;
(8) Betameprodine;
(9) Betamethadol;
(10) Betaprodine;
(11) Clonitazene;
(12) Dextromoramide;
(13) Diampromide;
(14) Diethyliambutene;
(15) Dimenoxadol;
(16) Dimepheptanol;
(17) Dimethyliambutene;
(18) Dioxaphetyl butyrate;
(19) Dipipanone;
(20) Ethylmethylthiambutene;
(21) Etonitazene;
(22) Etoxeridine;
(23) Fenethylline;
(24) Furethidine;
(25) Hydroxypethidine;
(26) Ketobemidone;
(27) Levomoramide;
(28) Levophenacylmorphan;
(29) Mecloqualone;
(30) Morpheridine;
(31) Noracymethadol;
(32) Norlevorphanol;
(33) Normethadone;
(34) Norpipanone;
(35) Phenadoxone;
(36) Phenampromide;
(37) Phenibut;
(38) Phenomorphan;
(39) Phenoperidine;
(40) Piritramide;
(41) Proheptazine;
(42) Properidine;
(43) Racemoramide;
(44) Tianeptine;
(45) Trimeperidine;
(46) Methaqualone;
(47) N-benzylpiperazine;
(48) 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-piperidinylidene]-benzenesulfonamide, W-18;
(49) N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine, also known as isotonitazene;
(50) 2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (butonitazene);
(51) 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (etodesnitazene, etazene);
(52) N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) (flunitazene);
(53) N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (metodesnitazene);
(54) N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine (metonitazene);
(55) 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (N-pyrrolidino etonitazene, etonitazepyne);
(56) N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (protonitazene);
(57) 7-[(10,11-dihydro-5 H -dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) (amineptine);
(58) N-phenyl-N′ -(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate) (mesocarb); and
(59) N-methyl-1-(thiophen-2-yl)propan-2-amine (methiopropamine).
An Act to add certain substances to Schedule I of the controlled substances schedule.
I certify that the attached Act originated in the:
Chief Clerk of the House
Speaker of the House
Attest:
Chief Clerk of the House
President of the Senate
Attest:
Secretary of the Senate
File No. ____ Chapter No. ______
|
Received at this Executive Office this _____ day of _____________,
2026 at ____________M.
for the Governor
The attached Act is hereby approved this ________ day of ______________, A.D., 2026
ss. Office of the Secretary of State
Filed ____________, 2026 at _________ o'clock __M.
Secretary of State
Asst. Secretary of State
|